Editorial: Resmetirom - a promising treatment option for NASH and liver fibrosis

Aliment Pharmacol Ther. 2024 Jan;59(1):128-129. doi: 10.1111/apt.17747.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Humans
  • Liver Cirrhosis / drug therapy
  • Non-alcoholic Fatty Liver Disease* / drug therapy
  • Pyridazines*
  • Uracil

Substances

  • resmetirom
  • Pyridazines
  • Uracil